Key facts
- This page summarizes Christopher M. Smith's Form 4 filing for NEOGENOMICS INC (NEO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Aug 2022, 19:13.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
Footnote F2
On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date.
Footnote F3
On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.